Background and objectives: Accurate assessment of the use of immunosuppressive medications is vital for observational analyses that are widely used in transplantation research. This study assessed the accuracy of three potential sources of maintenance immunosuppression data. Design, setting, participants, & measurements: This study investigated the agreement of immunosuppression information in directly linked electronic medical records for Medicare beneficiaries who received a kidney transplant at one center in 1998 through 2001, Organ Procurement and Transplantation Network (OPTN) survey data, and Medicare pharmacy claims. Pair-wise, interdata concordance () and percentage agreement statistics were used to compare immunosuppression re...
Background. This study investigated medication adherence in kidney transplant patients (KTPs) conver...
Belatacept, a CTLA4-Ig, was designed to prevent rejection and graft loss in kidney transplant recipi...
Objectives: The present single centre study aims at analyzing the impact on renal allograft outcome ...
Data of long-term immunosuppressive protocol comparison are lacking. The goal of this study was to c...
Background. Nonadherence to immunosuppression after kidney transplant is an important contributor to...
Background: Although optimization of immunosuppressive schemes in renal transplantation have minimiz...
Annual assessment of adherence would strengthen long-term outcome assessments from registry data. Th...
BACKGROUND: Although optimization of immunosuppressive schemes in renal transplantation have minimiz...
Abstract Background Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only ...
Objective: To examine current immunosuppressive regimens administered to kidney transplant recipient...
AIMS OF THE STUDY Primary maintenance immunosuppressive therapies for renal transplant re...
Background Non-adherence (NA) to immunosuppressants (IS) among renal transplant recipients (RTRs)...
ObjectiveTo review the literature relating to immunosuppressant drug measurement as performed in the...
Following solid organ transplantation individualizing the immunosuppressive therapy to obtain an opt...
<b><i>Background:</i></b> Limited data exist on medication use aside from immunosuppression among la...
Background. This study investigated medication adherence in kidney transplant patients (KTPs) conver...
Belatacept, a CTLA4-Ig, was designed to prevent rejection and graft loss in kidney transplant recipi...
Objectives: The present single centre study aims at analyzing the impact on renal allograft outcome ...
Data of long-term immunosuppressive protocol comparison are lacking. The goal of this study was to c...
Background. Nonadherence to immunosuppression after kidney transplant is an important contributor to...
Background: Although optimization of immunosuppressive schemes in renal transplantation have minimiz...
Annual assessment of adherence would strengthen long-term outcome assessments from registry data. Th...
BACKGROUND: Although optimization of immunosuppressive schemes in renal transplantation have minimiz...
Abstract Background Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only ...
Objective: To examine current immunosuppressive regimens administered to kidney transplant recipient...
AIMS OF THE STUDY Primary maintenance immunosuppressive therapies for renal transplant re...
Background Non-adherence (NA) to immunosuppressants (IS) among renal transplant recipients (RTRs)...
ObjectiveTo review the literature relating to immunosuppressant drug measurement as performed in the...
Following solid organ transplantation individualizing the immunosuppressive therapy to obtain an opt...
<b><i>Background:</i></b> Limited data exist on medication use aside from immunosuppression among la...
Background. This study investigated medication adherence in kidney transplant patients (KTPs) conver...
Belatacept, a CTLA4-Ig, was designed to prevent rejection and graft loss in kidney transplant recipi...
Objectives: The present single centre study aims at analyzing the impact on renal allograft outcome ...